Liquid biopsy is an advanced cancer diagnostic method that detects cancer using bio-fluids such as plasma, blood, urine, and cerebrospinal fluid (CSF). For cancer diagnosis, this non-invasive diagnostic test uses circulating tumor cells (CTC), circulatory nucleic acids, and exosomes as biomarkers.
By the end of 2027, the global liquid biopsy market is expected to be valued at US$ 3,535.1 million.
Get Your FREE Sample Copy of the Liquid Biopsy Market Report 2021
Global Liquid Biopsy Market: Drivers
Over the forecast period, rising cancer prevalence is a key factor driving growth of the global liquid biopsy market. According to World Health Organization (WHO), cancer caused around 18.1 million new cancer cases, as well as 9.6 million death cases globally in 2018.
Furthermore, growing funding for cancer R&D is expected to help the global liquid biopsy market grow. For instance, cancer research fund by NCRI allies, touched around US$ 750 million in 2018/19, according to the National Cancer Research Institute (NCRI).
In 2019, in terms of value, North America held the largest share in the global liquid biopsy market, with a 50.7 %, trailed by Europe.
Global Liquid Biopsy Market: Restraints
Circulating free DNA (cfDNA) levels varies in plasma and serum. Such variations in cfDNA levels between patients might result in erroneous or unreliable liquid biopsy test results, limiting the global liquid biopsy market’s growth.
Furthermore, the global liquid biopsy market growth is expected to be restricted by the high cost of liquid biopsy. The equipment and reagents costs, as well as labor and professional fees, are all expenses related with liquid biopsy.
Ask for PDF sample copy of the Liquid Biopsy market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1223
Global Liquid Biopsy Market: Opportunities
The meticulous operation of fluid within sub-millimeter channels is the characteristic of microfluidics. Many studies for the growth of lab-on-a-chip devices aimed at the biochemical investigations such as protein and DNA analysis, cell separation, and amplification of PCR are currently in progress.
Furthermore, the use of cfDNA for detecting tumor progression and alterations is anticipated to provide profitable growth prospects for market players.
The ctNA (Circulating Tumor Nucliec Acids) segment of the global liquid biopsy market was worth US$ 250.0 million in 2019 and is predicted to grow at a 27.3 % CAGR to US$ 1,723.6 million by 2027 over forecast period.
Market Trends/ Key Takeaways
Breast milk is being studied for use in breast cancer diagnosis. For instance, Dr. Katrina Mitchell, MD, fellowship-trained breast surgeon of IBCLC, FACS, in February 2020 collaborated with cancer researchers of University of Massachusetts-Amherst to evaluate the utilization of breast milk from nursing women to determine pathogenic BRCA2 or BRCA1 genetic mutations.
Global Liquid biopsy market players are concentrating their efforts on forming partnerships with several institutions for liquid biopsy R&D. Chugai Pharmaceutical Ltd., and Foundation Medicine teamed up with the National Cancer Center (NCC) in February 2020 for the third stage of SCRUM-Japan, a cancer genomic screening consortium in Japan, for using FoundationOneLiquid, Foundation Medicine’s laboratory-developed liquid biopsy test.
View Press Release For More Information
Global Liquid Biopsy Market: Competitive Landscape
The following companies are key players in the global liquid biopsy market: Silicon Biosystems, Pathway Genomics Corporation, Biocept, Inc., Natera, Inc., Sysmex Corporation, F. Hoffmann-La Roche Limited., Trovagene, Inc., Qiagen N.V., MDxHealth SA, and Janssen Global Services.
Global Liquid Biopsy Market: Key Developments
Key players are focusing on partnership approaches to extend their product range. For instance, Saga Diagnostics, partnered with the Laboratoires Servier in January 2020 to conduct testing of liquid biopsy on the cancer patients engaged in clinical research.
Major market players are similarly concentrating their efforts on showcasing their products in the symposiums. For instance, at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in January 2020, GRAIL Inc. introduced new data from their liquid biopsy trial, CCGA, which was unsuccessful to show a significant development in sensitivity as compared to data presented during the symposium 2019.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Sample Type
- Market Snippet, By Disease Indication
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
- Market Dynamics
- Global Liquid Biopsy Market, By Biomarker Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- CTC (Circulating Tumor Cells)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- ctNA (Circulating Tumor Nucliec Acids)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- Exosomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- Introduction
- Global Liquid Biopsy Market, By Sample Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2027, (US$ Mn)
- Introduction
- Global Liquid Biopsy Market, By Disease Indication 2019– 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Lung Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Gastrointestinal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Prostate Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Breast Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Colorectal Cancer
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Leukemia
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Liquid Biopsy Market, By End User 2019– 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Cancer Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Academic Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Liquid Biopsy Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Biomarker Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Disease Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1223
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837